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ABSTRACT 
 
Pregnant  women  are  highly  vulnerable  to  malaria  infection  in  its  endemic  areas,  particularly 
infection  by  Plasmodium  falciparum  that  can  cause  premature,  low  birth  weight,  severe  anemia  in 
pregnant women, and death. Sulfadoxine-pyrimethamine (SP) for Intermittent Preventive Treatment 
for  pregnant  (IPTp)  is  used  for  malaria  control  in  pregnancy  recommended  by  the  World  Health 
Organization that has already been implemented in Africa. The P. falciparum resistance to SP has been 
reported  in  several  malarial  endemic  areas,  and  mutations  in  the  genes  of  Plasmodium  falciparum 
Dihydrofolate Reductase  (Pfdhfr) and Dihydropteroate Synthase  (Pfdhps) are shown to be associated 
with parasite resistance to SP treatment. Genetic analysis of Pfdhfr and Pfdhps genes in pregnant women 
infected with P. falciparum has not yet been examined in Indonesia.   The cross-sectional study was 
conducted at two subdistricts, Sungai Pinang and Peramasan, in Banjar district of South Kalimantan 
Province,  where  127  pregnant  women  were  recruited  from  2008  to  April  2010.  Two  important 
mutations in Pfdhfr gene (amino acid positions at N51 and S108) and three in Pfdhps gene (A437, K540 
and A581) were analyzed by nested PCR-RFLP method. All of the seven pregnant women samples 
infected with P. falciparum presented PfDHFR 108N and PfDHPS 437G mutations. One of the samples 
had  the  additional  mutation  at  PfDHPS  540,  in  which  Lys  is  substituted  by  Glu.  These  results 
suggested that P. falciparum might present only some resistance to SP at Sungai Pinang and Peramasan 
subdistricts,  Banjar  District,  South  Kalimantan  province,  Indonesia.  Although  there  were  limited 
number of samples, this study showed only few mutations of Pfdhfr and Pfdhps genes in P. falciparum at 
Banjar district, South Kalimantan Province, that suggests SP might be effective for IPTp in this area. 
Thus, further analysis of the other mutation sites in Pfdhfr and Pfdhps genes and in vivo efficacy study 
of SP with more sufficient sample numbers will be necessary to confirm this preliminarily result. 
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BACKGROUND 
Pregnant women in malaria endemic areas are 
highly  vulnerable  to  malaria  infection, 
particularly  Plasmodium  falciparum  (P.  falciparum) 
infection  that  can  cause  prematurity,  low  birth 
weight  (LBW),  severe  anemia  and  death. 
Complications are more common  in  the  Primi- 
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gravidae  than  multigravidae  [1-3].  As  a 
consequence   of    the   impact   of   malaria   on 
pregnancy,  malaria  control  during  pregnancy 
requires  the  highest  attention  and  carefulness. 
World  Health  Organization  (WHO)  has 
recommended  the  use  of  sulphadoxine-
pyrimethamine  (SP)  for  intermittent  preventive 
treatment (IPT) for malaria control in pregnancy. 
This policy has been implemented in Africa [4]. 
SP has been proven safe for the second and third 
trimester  of  pregnancy.  It  has  an  affordable 
price,  is  widely  available,  needs  a  single  dose 
treatment and is effective in reducing the risk of 
LBW and placental malaria [5-7]. Fitriah, et al., 2012 
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However,  the  level  of  resistance  to  SP  has 
increased and rapidly spread due to the parasite’s 
ability to perform gene mutation as a response to 
drug  pressure,  that  is,  the  occurrence  of  point 
mutations in genes that are targeted by the drug 
[8].  Monitoring  molecular  markers  of  SP 
resistance  is  very  valuable  to  determine  drug 
policy  for  the  prevention  and  treatment  of 
malaria in pregnancy [9]. Mutations in PfDHFR 
and    PfDHPS  genes  are  associated  with 
resistance of P. falciparum to SP. Key mutations 
of resistance to pyrimethamine is PfDHFR gene 
mutation at codon 108 which has been a change 
SerAsn or SerThr, and point mutations in 
three  other  codons  of  51  [AsnIle],  59 
[CysArg],  and  164  [IleLeu].  Mutations  in 
PfDHPS  associated  with  resistance  to 
sulfadoxine  is  SerAla  or  SerPhe  at  codon 
436, AlaGly at codon 437, LysGlu at codon 
540,  AlaGly  at  codon  581,  AlaThr  or 
AlaSer at codon 613[10-19]. The presence of 
mutations  at  codons  437  and  540  of  PfDHPS 
together  with  the  triple  mutation  of  PfDHFR 
[quintuple mutation] is a significant predictor of 
SP treatment failure [20].  
In  Indonesia,  SP  had  been  used  as  an 
alternative malaria drug since 1999 [21] and was 
still used in Banjar district until 2009 [22]. The 
first  cases  of  SP  resistance  in  Indonesia  were 
encountered  in  1979  [23],  followed  by  their 
occurences in several provinces of Indonesia [24-
26].  Research  on  the  effectiveness  of  SP  in 
association  with  mutations  of  genes  coding  for 
PfDHFR  and  PfDHPS  in  several  malarial 
endemic  areas  and  also  in  pregnant  women  in 
several  malarial  endemic  areas  in  Africa  have 
been  conducted  [24-29].  Therefore,  World 
Health  Organization  released  the 
recommendation  of  a  threshold  of  a  parasite 
genetic marker of SP-resistance (50% prevalence 
of the pfdhps 540) above which SP-IPTp is not 
recommended  for  use  in Africa  [30]. However, 
no  information  is  available  in  particular  for 
pregnant  women  infected  with  P.  falciparum  in 
malaria  endemic  areas  in  Indonesia. This  study 
aims to determine the mutations of Pfdhfr and 
Pfdhps genes in pregnant women infected with 
P.  falciparum  at  Peramasan  and  Sei  Pinang 
subdistricts,  Banjar  District,  South  Kalimantan 
Province, that belong to malaria endemic areas. 
 
MATERIALS AND METHODS 
Study sites   
The study was carried out at two subdistricts, 
Sungai Pinang and Peramasan, in Banjar district, 
South Kalimantan Province. The topography of 
Peramasan  subdistrict  is  mountainous  and 
surrounded  by  dense  forests  and  shrubs,  with 
small rivers in between meetings of the mountain 
[see  Figure  1].  The  population  was  3,730 
inhabitants  in  which  most  people  work  as 
farmers  and  traditional  gold  miners.  Sungai 
Pinang  is  an  area  of  rolling  hills  scattered  in 
mountainous  areas  Meratus  in  which  some 
villages belong to remote areas. The population 
was 16,245 inhabitants in 2008 in which most of 
people  work  as  farmers.  The  most  common 
vectors  are  Anopheles  balabacensis,  Anopheles 
maculatus,  Anopheles  letifer,  Anopheles  umbrosus, 
Anopheles kochi, Anopheles nigerrimus, and Anopheles 
vanu [22]. 
 
Figure 1.  Sampling positions at Sungai Pinang (green) and 
Peramasan sub districts (blue). 1. Kupang Rejo 
village; 2.  Sungai  Pinang; 3.  Pakutik;  4.  Rantau 
Nangka;   5.  Rantau  Bakula;  6. 
Belimbing  Baru;  7.  Peramasan  Atas;    8. 
Peramasan Bawah;  9.   Remo; 10. Angkipih; 11. 
Belimbing Lama; 12. Sumber Baru; 13. Sumber 
Harapan; 14. Kahela’an; 15. Hakim Makmur 
 
Participants  
The  cross-sectional  study  was  conducted. 
Pregnant women presenting for routine antenatal 
care  at  Sungai  Pinang  and  Peramasan  Health 
Centres were recruited from 2008 to April 2010. 
The study protocol was reviewed and approved 
by  the  Ethics  Committee  of  Medical  Research, 
Faculty  of  Medicine,  Airlangga  University, 
Surabaya, No. 26 /EC / KEPK /FKUA  /2010. 
Informed  consent  was  obtained  from  all 
participants.  
 
Species Identification 
Malaria  screening  used  Giemsa  stained  thin 
and  thick  blood  smears  under  microscopy  by 
local  staffs.  Blood  samples  for  the  molecular 
analysis were collected on filter paper (Advantec, 
Toyo Roshi Kaisha, Ltd., Japan). Malaria parasite 
densities were counted per 200 white blood cells 
(WBC) on Giemsa stained thin and thick smears, Polymorphism of Plasmodium Falciparum Dihydrofolate Reductase and Dihydropteroate Synthase Genes 
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calculated  as  parasites  per  microliter. 
Submicroscopic  plasmodial  infections  and 
parasite  species  were  assessed  by  nested 
polymerase  chain  reaction  (PCR)  assays  after 
extraction  of  DNA  from  filter  paper  (QIAmp 
Blood Kit, Qiagen, Hilden, Germany). 
 
 Detection of the PfDHFR and PfDHPS 
mutations.  
We analyzed two point mutations in the Pfdhfr 
gene (51 and 108) and three point mutations in 
the Pfdhps gene (437, 540 and 581). The detection 
of mutations in Pfdhfr and Pfdhps was carried out 
by  using  nested  PCR  followed  by  restriction 
fragment  length  polymorphism  (RFLP)[31-32]. 
The  first-round  PCR  amplification  was 
performed in a 20 l mixture containing 2 l of 
DNA  sample,  200  M  dNTP, 0.4  M  of  each 
primer,  as  described  by  previouse  report  [33], 
and  1  U  Taq  polymerase  (Takara  Ltd,  Japan). 
Nested PCR was performed in a 15 l mixture 
containing  2  l  of  the  first  PCR  product  with 
10X  dilution.  RFLP  was  performed  by 
administering the enzyme digestion at optimum 
temperature and time required as in the brochure 
from  the  manufacturer.  Five  microliters  of 
nested  PCR  products  were  used  without 
purification  in  the  total  volume  of  50  l 
containing 5 U/ l enzyme digestion, 5 l buffer, 
5 l BSA and 30 l distilled water. The digestion 
products  were  detected  by  ethidium  bromide 
stained  2%  agarose  gel  under  UV  light  after 
electrophoresis.  For  the  Pfdhfr  mutations,  AluI 
cut only the wild-type gene (S108), BsrI cut only 
the mutant gene (108N) and ScrFI cut only the 
mutant gene (108T).  Tsp509I only cut the wild-
type gene (51I). For the Pfdhps mutations, AvaII 
cut only the mutant gene (437G), FokI cut only 
the mutant gene (540E) and BstUI cut only the 
mutant gene (581G). For each series of samples, 
water  was  used  as  a  negative  control.  For  the 
detection  of  108N,  3D7-DNA  was  used  as  the 
wild-type  control,  K1-DNA  was  used  as  the 
mutant  control  of  108N,  and  FCR3-DNA  was 
used  as  the  mutant  control  of  108T.  For  the 
detection of 437G, FCR3-DNA was used as the 
wild-type control, while 3D7 and K1-DNA were 
used as the mutant control of 437G.  
 
RESULT AND DISCUSSION 
Subject Characteristics 
Total 127 pregnant women were involved in 
this  study,  consisting  of  30  pregnant  women 
from Peramasan Health Centre and 97 pregnant 
women from Sungai Pinang Health Centre (HC). 
Most of the pregnant women aged between 20-
30 years, 60% in Peramasan HC and 54% in Sei 
Pinang HC. They represented mostly at the first 
pregnancy  (primigravida)  compared  with  at  the 
second  pregnancy  and  the  third  or  more 
pregnancy,  13  [43%]  in  Peramasan  HC  and  48 
[49%] in Sei Pinang HC.   
 
Species Identification 
In Peramasan HC, malaria screening resulted 
in 10 pregnant women infected with Plasmodium, 
while  13  pregnant  women  were  infected  with 
Plasmodium  in  Sungai  Pinang  HC.  The  species 
identification  by  nested  PCR  resulted  in  12 
malaria  cases  among  these  pregnant  women,  6 
pregnant women with malaria occurred in each 
health  centre.  The  identification  of  malaria 
parasites infected to pregnant women was shown 
in  Table  1.  The  pregnant  women  with  malaria 
were manifested in the fever that appeared as a 
dominant malarial symptom. 
 
Mutations of PfDHFR and PfDHPS 
Genes 
Six  of  seven  samples  pregnant  women  with 
malaria  falciparum  had  the  double  mutation 
which consisted of PfDHFR 108N mutation and 
the single mutation of PfDHPS gene 437G. One 
sample had the triple mutations which consisted 
of 108N mutation in pfdhfr gene and the double 
mutation of PfDHPS (437G and 540E). The 51I 
and 108T mutations in the Pfdhfr gene and the 
581G  mutation  in  the  Pfdhps  gene  were  not 
observed in this study (see table 2). 
We  found  two  types  of  PfDHFR,  PfDHPS 
mutants  in  seven  P falciparum  isolates  in  Banjar 
district, particularly in Sei Pinang and Peramasan 
subdistricts.  All isolates, except one, contained 
the  PfDHFR  108N/PfDHPS  437G  double 
mutant.  One  isolation  contained  the  PfDHFR 
108N/PfDHPS  437G/540E  triple  mutant. 
Recently,  PfDHPS  540E  mutant  has  been 
demonstrated  as  a  predictor  for  P.  falciparum 
resistance  to  SP.  When  PfDHPS  540E  mutant 
was joined together with the triple mutation of 
PfDHFR as the quintuple mutation, it indicates a 
significant  predictor  of  SP  treatment  failure. 
Below  50%  prevalence  of  the  PfDHFR  540 
mutation  is  used  as  a  threshold  of  a  parasite 
genetic marker of SP-resistance, in the program 
of  Intermittent  Preventive  Treatment  (IPT) 
during  infancy  in  Africa  [20,  30,  34,  35].  One 
isolate containing PfDHPS 540E mutant found 
in our study with the mutation of PfDHFR 108N 
and  mutation  of  PfDHPS  437G  as  the  triple Fitriah, et al., 2012 
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mutations.  The  other six  isolates  presented  the 
wild  type  K540  PfDHPS,  and  it  suggested 
parasites  might  be  quite  sensitive  to  SP 
treatment.  However,  further  studies  with 
sufficient  numbers  of  samples  are  required  for 
finding  out  the  appropriate  prevalence  of 
PfDHPS  540E  mutant  in  order  to  provide  the 
recommendation for SP-IPTp implementation in 
Indonesia.  Moreover,  one  needs  to  clarify  the 
other  point  mutations  in  association  to  SP 
resistance  by  in  vivo  study  for  efficacy  of  SP 
combined with the analysis of molecular marker 
of SP resistance. 
 
 
Table 1. The determintaion of malaria parasites in pregnant women with malaria 
Health Centre      Microscopy*        Nested PCR 
      Pf  Pv  Mix Pf and Pv    Pf  Pv  Mix Pf and Pv 
 
Sungai Pinang    1  5    4    1  3    2 
Peramasan    3  6    4    3  2    1 
 
* Malaria screening used Giemsa stained thin and thick blood smear under microscopy.  
Pf: P. falciparum, Pv: P.  Vivax; Mix Pf and Pv: mixed infection of Pf and Pv 
 
 
Table 2.   PfDHFR and PfDHPS gene mutations, and density of parasites /ul blood sample in pregnant women infected 
with P. falciparum in Sungai Pinang and Peramasan Health Centers  
 
Sample 
Microscopy  Nested PCR-RFLP 
  PfDHFR  PfDHPS 
Pf  Mix Pf and Pv  density of parasites / ul  51  108  437  540  581 
KH1  Pf    35405  asn  asn  gly  lys  ala 
KH6*    mix   33742  asn  asn  gly  lys  ala 
KH9    mix   320  asn  asn  gly  glu  ala 
KH14*  Pf    45962  asn  asn  gly  lys  ala 
KH16*    mix   4815  asn  asn  gly  lys  ala 
KH17  Pf    2395  asn  asn  gly  lys  ala 
KH23  Pf    6834  asn  asn  gly  lys  ala 
Mix Pf and Pv: mixed infections of Pf and Pv;  Mutated codon is marked with bold letters;  * Samples from the Sungai 
Pinang health center  
 
There  were  two  types  of  isolates  containing 
PfDHFR  and  PfDHPS  mutants  in  Peramasan 
subdistrict. In fact, the people’s mobilization was 
high  in  here  due  to  the  development  of  social 
and  economy,  i.e.  mining  in  the  forest, 
plantations  and  agricultural  industries.  The 
workers in mining and forestry are seasonal and 
come not only from South Kalimantan but also 
from various regions in Indonesia, including Java 
and Papua that belong to malaria endemic areas 
[22, 36]. So, there is a great chance for the spread 
of  PfDHFR  and  PfDHPS  mutants  from  other 
malaria  endemic  areas  such  as  Java  or  Papua. 
Whereas in Sungai Pinang subdistrict, there was 
one  type  of  isolations  containing  PfDHFR  and 
PfDHPS  mutants  (PfDHFR  108N/PfDHPS 
437G).  The  people’s  mobilization  in  here  was 
low.  However,  the  limited  isolations  found  in 
Sungai  Pinang  were  not  easy  to  illustrate  this 
matter. 
Based  on  the  previous  studies  in  Indonesia 
and  its  neighboring  countries,  the  pattern  of 
mutations  of  PfDHFR  and  PfDHPS  genes  in 
isolations  was  various.  For  instance,  in 
Purworejo, Central Java, there was found a single 
mutation of PfDHFR gene 108N/108T or paired 
with  59R/164L  and  a  single  mutation  of  
PfDHPS gene 437G or paired with the 540E. In 
Sumba and Timor Leste, there was obtained the 
108N and 51I double mutations in Pfdhfr gene 
and a single 437G mutation in Pfdhps gene [36-
39]. In Papua New Guinea, there was found the 
gene  mutation  108N  and  59R  and  single 
mutation  PfDHPS    437G  or  paired  with  the 
540E  [38,  41].   Our  study  analyzed  only  two 
codons  of  51  and  108  in  Pfdhfr  gene  and 
detected mutation at 108 only, while 5.  the other 
possible  mutation  at  59  has  been  reported  in 
Indonesia  and  Southeast  Asia  [42].  So,  it  is 
possible that the mutations of PfDHFR gene in 
pregnant  women  with  falciparum  malaria  who 
live  in  Sungai  Pinang  and  Peramasan  may  not 
only carry the one mutation but also may carry 
the  other  mutations,  including  the  mutation  in 
codon of 59 and of 164.  This codon needs to be 
analyzed  in  further  study,  whereabout  the 
presence  of  triple  mutations  of  PfDHFR 
together with two mutations of PfDHPS (437G 
and  540E)  could  be  the  predictor  for  SP 
resistance [20, 30].  Polymorphism of Plasmodium Falciparum Dihydrofolate Reductase and Dihydropteroate Synthase Genes 
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Pregnant  women  with  malaria  having  no 
willing to participate and no visiting HC due to 
their  homes  in  remote  areas  might  cause  the 
limited  isolations  in  our  study.  On  the  other 
hands,  the  prevalence  of  malaria  in  pregnant 
women was 35.7% in three months under active 
detection by Riyanto [36], 12.8% under passive 
detection at the two health centers in the study 
sites,  and  most  people  living  in  these  areas 
(83.3%)  used  bed-nets  in  2008  under  research 
observation by WHO  (unpublished). There is a  
good road now with a public transportation from 
HC to a district hospital, which creates an ease 
for for people movements. These environmental 
situation  change  might  have  influenced  to  our 
study of limited number of sample isolations. 
Even  though  limited  number  of  malaria 
infected pregnant women could be recruited and 
some  of  the  important  mutation  sites  were 
analyzed in this preliminary study yet, we could 
provide  a  basic  important  information  and 
necessity  of  further  malaria  drug  resistance 
information  to  guide  drug  policy  on  the 
prevention  and  treatment  of  malaria  in 
pregnancy. 
 
CONCLUSION 
Although  there  was  limited  number  of 
samples, this study shows only a few mutations 
of PfDHFR and PfDHPS gene in P. falciparum at 
Banjar district, South Kalimantan Province, that 
suggests  SP  might  be  effective  for  IPTp 
resistance  to  SP  at  this  area.  Thus,  further 
analysis of the other mutation sites in Pfdhfr and 
Pfdhps  genes  and  in  vivo  efficacy  study  of  SP 
with  more  sufficient  sample  numbers  will  be 
necessary  to  confirm  this  preliminarily  result. 
Therefore, further research is needed with a lot 
of  isolations  for  the  sake  of  1]  clarifying  more 
the point of mutation in relation to SP resistance 
by  in  vivo  study  for  efficacy  of  SP  combined 
with  analysis  of  molecular  marker  of  SP 
resistance,  2]  finding  out  the  appropriate 
prevalence  of  PfDHPS  540  mutant,  and  3] 
finding out the predictive value of the PfDHFR 
and PfDHPS mutations for IPT with SP. 
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